Introduction
Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing epithelial cells and smooth muscle proliferation within the prostatic transition area. It is a common disease with lower urinary tract symptoms in middle-aged and elderly males, which is becoming more prevalent in parallel with the aging of demographic structures in China [
1]. In recent years, the overall morbidity of elderly males was approximately 50%, and the prevalence of BPH is about 70% in men over 70 years old [
2‐
4]. There are many medical and surgical treatment choices for BPH, such as medical drugs, traditional Chinese medicine, physiotherapeutic techniques, surgical approaches, and combination therapy [
5,
6]. When these conservative therapies were invalid for BPH, surgical approaches were considered necessarily. Transurethral resection of the prostate (TURP) had always been considered the “gold standard” because of its well-documented efficacy and low-cost burden in the past decades [
7]. Nowadays, improvements in medical equipments and techniques have made surgical choices become to more diverse for BPH, such as TURP, plasmakinetic enucleation of the prostate (PKEP), laser enucleation (holmium laser, thulium laser, green laser), photoselective vaporization of the prostate and other approaches. However, so many surgical treatments have made some discrepancies and controversies regarding their complications, safety profile, and sexual function among these surgical approaches [
8,
9].
In the past twenty years, TURP and PKEP were the two main types of surgical approaches in our hospital, many previous studies had been reported about their comparisons on clinical efficacy, and most of researchers considered that PKEP and TURP had a similar clinical efficacy. Nevertheless, controversies regarding surgical features, complications, and sexual function have never stopped, so more studies should be performed to update and validate these debatable topics [
10]. For these reasons, we collected 850 eligible cases of BPH who underwent PKEP or TURP in our hospital from March 2015 to March 2018. Then, an observation study was performed to assess the differences of complications, safety profile, sexual function, and other concerns between TURP and PKEP.
Discussion
For many years ago, open prostatectomy had been the primary option in BPH patients until it was gradually replaced by TURP. Since then, TURP has been applied in the treatment of BPH for decades, which was recognized as the “golden standard” owing to its clinical efficacy [
15]. In previous studies, many researchers have discussed the differences of TURP compared with other surgical procedures, including clinical efficacy, safety profile, sexual function, and so on, but there was no consensus about these topics [
16,
17]. In this study, only Q
max appeared to have a significant difference with the minor gap, and no significant differences were observed in IPSS, QoL, and PVR between the two groups during the follow-up. The results of our study demonstrated that TURP has comparable clinical efficacy in contrast to PKEP, and these findings in IPSS, QoL and PVR were similar to previous studies performed by others [
18‐
20].
In this study, the operative time, intraoperative irrigation volume, postoperative hemoglobin, decrease in hemoglobin, postoperative irrigation time and volume, catheterization time, and hospital stay of PKEP were significantly less than those of TURP (
P < 0.05), which indicated that PKEP has some merits in operation time, irrigation time and volume, catheterization time, blood loss, and hospital stay [
21]. To compare the differences of complications or adverse events in the two groups, about 20 parameters were enrolled in this study, and our results showed that the incidences of massive blood loss, postoperative secondary bleeding, blood transfusion, capsular perforation, urinary tract irritation, bladder spasm, clot retention, urinary tract infection, transient incontinence, and erectile dysfunction of the PKEP group were significantly lower than those of the TURP group (
P < 0.05). These findings suggested that PKEP has less complication and better safety profile, and this viewpoint was also supported by a study reported by Li S et al. [
22]. The Clavien–Dindo classification was widely used in many surgical reports, which was a 5-scale classification of surgical complications based on the type of treatment for complications [
23]. We used it for grade assessment of complications, and our results showed that the incidences of II, III grade in the Clavien–Dindo classification of PKEP were significantly lower than those of TURP (
P < 0.05), which also suggested that PKEP have better safety profile compared with TURP.
At the early stage of development in TURP technique, transurethral resection syndrome was one of the most serious complication of TURP. In recent years, improvements in surgical skills and medical technology made transurethral resection syndrome very rare. In this study, the incidence of transurethral resection syndrome was 0.43% in the TURP group. One patient suffered from transurethral resection syndrome in the TURP group in contrast to none in the PKEP group. In PKEP, 0.9% saline solution was used for irrigation, and it can significantly reduce the risk of dilutional hyponatremia and transurethral resection syndrome. In addition, vaporized resection of PKEP can generate coagulation at the tissue interface, which will make a quick close for small blood vessels and capillaries, consequently preventing reabsorption of the irrigation solution [
24]. Moreover, PKEP using a bipolar plasmakinetic system can achieve cutting and coagulation simultaneously with a plasma-loop electrode. Compared with satisfactory hemostasis of PKEP, some conditions caused by more blood loss in TURP will increase the incidence of hemorrhage-related complications. In this study, we also considered that the differences in blood loss and blood transfusion between the two groups were related to this coagulation and hemostasis.
A previous study considered that the good hemostasis of PKEP can shorten the catheterization and hospitalization time [
25]. In the view of results in our study, the endoscopic vision and lower cutting temperature in PKEP technique should be taken into account. Firstly, a clear view offered by better hemostasis not only can shorten operation time and irrigation volume but also reduce complications and iatrogenic injury such as capsular perforation and bladder injury. Secondly, the high loop-cutting temperature of TURP will result in thermal injury and wound scarring. When the scar was dropped out during wound self-healing, subsequently leads to secondary hemorrhage after operation, which also increases the catheterization time and hospital stay. Moreover, the temporary urinary tract irritation after operation in TURP may be caused by thermal injury, thermal-related inflammation, and tissue edema [
26,
27]. Hence, a higher incidence of urinary tract irritation in TURP was observed compared with PKEP. There were two patients who suffered from permanent incontinence in PKEP, and the specific cause was not very clear, which may be related to injury of urethral sphincter or diabetic neurogenic bladder dysfunction [
28].
In this study, the postoperative IIEF-5 score of the PKEP group was significantly higher than that of the TURP group, and the incidence of erectile dysfunction (increased cases after operation) in the PKEP group was significantly lower than that of the TURP group. During the operation, PKEP can offer a clear visual field and reduce probability of nerve injury, and it will alleviate the negative impact on sexual function, which may be responsible for better sexual function in PKEP. On the other hand, some dissimilarities among psychological aspects, sexual culture and concept from different areas should be taken into account, most Chinese elder people were ashamed of facing sex and related topics, and some patients’ obscure responses toward the survey may become a confounding factor to interpret these results objectively. Presently, the change in sexual function after operation is a debatable topic among studies from different areas and countries [
17,
29]. Therefore, more studies regarding this discrepancy are required for a definite conclusion.
In our study, some limitations should be presented here. Firstly, at the beginning of this study, the randomized controlled design was planned to apply, but too many patients after allocation had made an unexpected alterations such as canceling in operation, asking for another procedure, or retreating in this study, and it's challenging for us to perform a randomized controlled trial of surgical procedures in this sample size. Ultimately, we only grouped by patients’ final procedures and made a comparative analysis by means of obtained patients’ data, which will dilute its referential merits in some way. Secondly, in the later stage of this study, patients always had a tendency to choose PKEP due to its merits in terms of less hospital stay, lower complications, and more comfort. Then, it resulted in a not even distribution of cases in each group (320 cases in TURP versus 530 cases in PKEP). Thirdly, some patients during three years of follow-up had once absence of IPSS, QoL, Qmax, PVR, or IIEF, and the absent value of one parameter was allowed to be filled by imputation except for the preoperative evaluation and the first postoperative evaluation. After that, a good retention of cases was presented in this study during follow-up. Nevertheless, it can generate a mild bias in the results even though the total of cases was no more than 30% in whole samples. In view of limitations mentioned above, more high-quality study with evidence-based medicine needs to be performed in the future.
To summarize, the clinical efficacy of PKEP is compared favorably with TURP during three years of follow-up, but PKEP has advantages in less thermal injury and blood loss, lower complications, and better safety profile, which may be more suited for high-risk patients such as cardiac pacemaker implantation or people taking anticoagulant / antithrombotic drugs [
30‐
32]. In conclusion, PKEP should be given a priority for BPH surgical treatment. However, in consideration of limitations in this study, our results need to be confirmed in well-designed and multicentre randomized controlled trials.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.